Intellia Therapeutics, Inc. (NTLA) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,821
Total Return
-81.79%
CAGR
-28.87%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.69% |
| Median | -3.54% |
| Best | +128.93% |
| Worst | -69.73% |
| % of Windows Positive | 39.9% |
1-Year (252 Trading Days)
| Average | -34.37% |
| Median | -43.23% |
| Best | +121.72% |
| Worst | -75.81% |
| % of Windows Positive | 12.3% |
3-Year (756 Trading Days)
| Average | -78.82% |
| Median | -81.71% |
| Best | -48.50% |
| Worst | -91.75% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -96.45% |
| Average Drawdown | -74.90% |
| Drawdown Duration | 1190 Trading Days (Unrecovered) |
| Sortino Ratio | -0.03 |
| Calmar Ratio | -0.30 |
| CVaR (5%) | -10.57% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +44.83% (+140.71% ann.) | +$4482.76 | $0.00 | $0.00 | $0.00 |
| 2025 | -22.90% | $2289.89 | $0.00 | $0.00 | $0.00 |
| 2024 | -61.76% | $6175.79 | $0.00 | $0.00 | $0.00 |
| 2023 | -12.61% | $1261.11 | $0.00 | $0.00 | $0.00 |
| 2022 | -70.49% | $7049.22 | $0.00 | $0.00 | $0.00 |
| 2021 | +117.35% | +$11735.30 | $0.00 | $0.00 | $0.00 |
| 2020 | +270.82% | +$27082.47 | $0.00 | $0.00 | $0.00 |
| 2019 | +7.47% | +$747.26 | $0.00 | $0.00 | $0.00 |
| 2018 | -28.98% | $2898.02 | $0.00 | $0.00 | $0.00 |
| 2017 | +46.61% | +$4660.55 | $0.00 | $0.00 | $0.00 |
| 2016 partial | -40.68% (-55.13% ann.) | $4067.87 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | May 6, 2016 – February 19, 2020 | -36.61% | -11.33% | $3660.63 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -14.84% | -84.02% | $1484.37 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +127.76% | +276.00% | +$12775.97 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +288.90% | +262.72% | +$28889.66 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -58.00% | -60.20% | $5800.37 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -57.25% | -36.78% | $5725.12 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -42.18% | -27.47% | $4218.48 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.